Evidence map›Paper›PMID 25404323›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody.

Enrico Malito, Marco Biancucci, Agnese Faleri, Ilaria Ferlenghi, Maria Scarselli, Giulietta Maruggi, Paola Lo Surdo, Daniele Veggi, Alessia Liguori, Laura Santini and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. EngineeringVaccines · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 2 countries.

Enrico MalitoNovartis Vaccines, 53100 Siena, Italy; and enrico.malito@novartis.com rino.rappuoli@novartis.com.
Marco BiancucciNovartis Vaccines, 53100 Siena, Italy; and.
Agnese FaleriNovartis Vaccines, 53100 Siena, Italy; and.
Ilaria FerlenghiNovartis Vaccines, 53100 Siena, Italy; and.
Maria ScarselliNovartis Vaccines, 53100 Siena, Italy; and.
Giulietta MaruggiNovartis Vaccines, 53100 Siena, Italy; and.
Paola Lo SurdoNovartis Vaccines, 53100 Siena, Italy; and.
Daniele VeggiNovartis Vaccines, 53100 Siena, Italy; and.
Alessia LiguoriNovartis Vaccines, 53100 Siena, Italy; and.
Laura SantiniNovartis Vaccines, 53100 Siena, Italy; and.
Isabella BertoldiNovartis Vaccines, 53100 Siena, Italy; and.
Roberto PetraccaNovartis Vaccines, 53100 Siena, Italy; and.
Sara MarchiNovartis Vaccines, 53100 Siena, Italy; and.
Giacomo RomagnoliNovartis Vaccines, 53100 Siena, Italy; and.
Elena CartocciNovartis Vaccines, 53100 Siena, Italy; and.
Irene VercellinoNovartis Vaccines, 53100 Siena, Italy; and.
Silvana SavinoNovartis Vaccines, 53100 Siena, Italy; and.
Glen SpraggonGenomic Institute of the Novartis Research Foundation, San Diego, CA 92121.
Nathalie NoraisNovartis Vaccines, 53100 Siena, Italy; and.
Mariagrazia PizzaNovartis Vaccines, 53100 Siena, Italy; and.
Rino RappuoliNovartis Vaccines, 53100 Siena, Italy; and enrico.malito@novartis.com rino.rappuoli@novartis.com.
Vega MasignaniNovartis Vaccines, 53100 Siena, Italy; and.
Matthew James BottomleyNovartis Vaccines, 53100 Siena, Italy; and.
Novartis (Italy) · ITGenomics Institute of the Novartis Research Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serogroup B Neisseria meningitidis (MenB) is a major cause of severe sepsis and invasive meningococcal disease, which is associated with 5-15% mortality and devastating long-term sequelae. Neisserial adhesin A (NadA), a trimeric autotransporter adhesin (TAA) that acts in adhesion to and invasion of host epithelial cells, is one of the three antigens discovered by genome mining that are part of the MenB vaccine that recently was approved by the European Medicines Agency. Here we present the crystal structure of NadA variant 5 at 2 Å resolution and transmission electron microscopy data for NadA variant 3 that is present in the vaccine. The two variants show similar overall topology with a novel TAA fold predominantly composed of trimeric coiled-coils with three protruding wing-like structures that create an unusual N-terminal head domain. Detailed mapping of the binding site of a bactericidal antibody by hydrogen/deuterium exchange MS shows that a protective conformational epitope is located in the head of NadA. These results provide information that is important for elucidating the biological function and vaccine efficacy of NadA.

Indexed as

Adhesins, BacterialAmino Acid SequenceAntibodies, BacterialAntigens, BacterialBinding Sites, AntibodyCrystallography, X-RayDeuterium Exchange MeasurementEpitope MappingMeningococcal VaccinesMicroscopy, Electron, TransmissionModels, MolecularMolecular Sequence DataNeisseria meningitidis, Serogroup BProtein IsoformsProtein MultimerizationProtein StabilityAdhesins, BacterialAntibodies, BacterialAntigens, BacterialMeningococcal VaccinesNadA protein, Neisseria meningitidisProtein Isoformscoiled coilhydrogen–deuterium exchangemeningitisthermostabilitytrimeric autotransporter adhesin

Identifiers

PMID25404323
PMCPMC4260552
OpenAlexW2094573352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.